Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice

Biochemical and Biophysical Research Communications

Volumn 452, Issue 1, 2014, Pages 53-59

  Zhang, Pengpeng ^a,b   Shan, Tizhong ^b   Liang, Xinrong ^b   Deng, Changyan ^a   Kuang, Shihuan ^b  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Cardiomyocyte; Heart failure; mTOR

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MTOR PROTEIN, MOUSE; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENERGY METABOLISM; FATTY ACID OXIDATION; GLYCOLYSIS; GROWTH RETARDATION; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; MOUSE; NONHUMAN; PERINATAL DEVELOPMENT; POSTNATAL GROWTH; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; HEART; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TOR SERINE-THREONINE KINASES;

EID: 84907816174     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.08.046     Document Type: Article

References (31)

1. S. Neubauer The failing heart - an engine out of fuel N. Engl. J. Med. 356 2007 1140 1151
2. S. Wullschleger, R. Loewith, and M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471 484
3. P. Polak, and M.N. Hall MTOR and the control of whole body metabolism Curr. Opin. Cell Biol. 21 2009 209 218
4. R. Zoncu, A. Efeyan, and D.M. Sabatini MTOR: from growth signal integration to cancer, diabetes and ageing Nat. Rev. Mol. Cell Biol. 12 2011 21 35
5. N. Hay, and N. Sonenberg Upstream and downstream of mTOR Genes Dev. 18 2004 1926 1945
6. R.R. Li, R.G. Wang, R.S. Zhai, and Z. Dong Targeted inhibition of mammalian target of rapamycin (mTOR) signaling pathway inhibits proliferation and induces apoptosis of laryngeal carcinoma cells in vitro Tumori 97 2011 781 786
7. S.W. Kim, S.M. Kim, H. Bae, D. Nam, J.H. Lee, S.G. Lee, B.S. Shim, S.H. Kim, K.S. Ahn, S.H. Choi, G. Sethi, and K.S. Ahn Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades Prostate 73 2013 296 305
8. L. Annovazzi, M. Mellai, V. Caldera, G. Valente, L. Tessitore, and D. Schiffer MTOR, S6 and AKT expression in relation to proliferation and apoptosis/autophagy in glioma Anticancer Res. 29 2009 3087 3094
9. V. Zinzalla, D. Stracka, W. Oppliger, and Michael N. Hall Activation of mTORC2 by association with the ribosome Cell 144 2011 757 768
10. P. Polak, N. Cybulski, J.N. Feige, J. Auwerx, M.A. Rüegg, and M.N. Hall Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration Cell Metab. 8 2008 399 410
11. M. Murakami, T. Ichisaka, M. Maeda, N. Oshiro, K. Hara, F. Edenhofer, H. Kiyama, K. Yonezawa, and S. Yamanaka MTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells Mol. Cell. Biol. 24 2004 6710 6718
12. Y. Zhu, K.M.P. Pires, K.J. Whitehead, C.D. Olsen, B. Wayment, Y.C. Zhang, H. Bugger, O. Ilkun, S.E. Litwin, G. Thomas, S.C. Kozma, and E.D. Abel Mechanistic target of rapamycin is essential for murine embryonic heart development and growth PLoS ONE 8 2013
13. D. Zhang, R. Contu, M.V.G. Latronico, J. Zhang, R. Rizzi, D. Catalucci, S. Miyamoto, K. Huang, M. Ceci, Y. Gu, N.D. Dalton, K.L. Peterson, K.-L. Guan, J.H. Brown, J. Chen, N. Sonenberg, and G. Condorelli MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice J. Clin. Invest. 120 2010 2805 2816
14. P. Shende, I. Plaisance, C. Morandi, C. Pellieux, C. Berthonneche, F. Zorzato, J. Krishnan, R. Lerch, M.N. Hall, M.A. Rüegg, T. Pedrazzini, and M. Brink Cardiac raptor ablation impairs adaptive hypertrophy alters metabolic gene expression, and causes heart failure in mice Circulation 123 2011 1073 1082
15. S. Sciarretta, P.Y. Zhai, and J. Sadoshima Rictor/mTORC2 is a critical mediator of cardiac hypertrophy and survival in response to pressure overload Circulation 122 2010
16. T. Shan, X. Liang, P. Bi, and S. Kuang Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle FASEB J. 27 2013 1981 1989
17. D.E. White, P. Coutu, Y.-F. Shi, J.-C. Tardif, S. Nattel, R. St. Arnaud, S. Dedhar, and W.J. Muller Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure Genes Dev. 20 2006 2355 2360
18. M. Whitnall, Y.S. Rahmanto, R. Sutak, X. Xu, E.M. Becker, M.R. Mikhael, P. Ponka, and D.R. Richardson The MCK mouse heart model of Friedreich's ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation Proc. Natl. Acad. Sci. 105 2008 9757 9762
19. M. Krenz, and J. Robbins Impact of beta-myosin heavy chain expression on cardiac function during stress J. Am. Coll. Cardiol. 44 2004 2390 2397
20. A.A. Kocher, M.D. Schuster, M.J. Szabolcs, S. Takuma, D. Burkhoff, J. Wang, S. Homma, N.M. Edwards, and S. Itescu Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat. Med. 7 2001 430 436
21. V. Risson, L. Mazelin, M. Roceri, H. Sanchez, V. Moncollin, C. Corneloup, H. Richard-Bulteau, A. Vignaud, D. Baas, A. Defour, D. Freyssenet, J.-F. Tanti, Y. Le-Marchand-Brustel, B. Ferrier, A. Conjard-Duplany, K. Romanino, S. Bauché, D. Hantaï, M. Mueller, S.C. Kozma, G. Thomas, M.A. Rüegg, A. Ferry, M. Pende, X. Bigard, N. Koulmann, L. Schaeffer, and Y.-G. Gangloff Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy J. Cell Biol. 187 2009 859 874
22. P. Teekakirikul, S. Eminaga, O. Toka, R. Alcalai, L.B. Wang, H. Wakimoto, M. Nayor, T. Konno, J.M. Gorham, C.M. Wolf, J.B. Kim, J.P. Schmitt, J.D. Molkentin, R.A. Norris, A.M. Tager, S.R. Hoffman, R.R. Markwald, C.E. Seidman, and J.G. Seidman Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta J. Clin. Invest. 120 2010 3520 3529
23. G.D. Lopaschuk, J.R. Ussher, C.D.L. Folmes, J.S. Jaswal, and W.C. Stanley Myocardial fatty acid metabolism in health and disease Physiol. Rev. 90 2010 207 258
24. G.E. Lyons, S. Muhlebach, A. Moser, R. Masood, B.M. Paterson, M.E. Buckingham, and J.C. Perriard Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle Development 113 1991 1017 1029
25. F. Haddad, A.X. Qin, P.W. Bodell, L.Y. Zhang, H. Guo, J.M. Giger, and K.M. Baldwin Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload Am. J. Physiol. Heart Circ. Physiol. 290 2006 H2351 H2361
26. S. Huang, L. Shu, J. Easton, F.C. Harwood, G.S. Germain, H. Ichijo, and P.J. Houghton Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity J. Biol. Chem. 279 2004 36490 36496
27. 2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure J. Clin. Invest. 117 2007 2431 2444
28. R. Ventura-Clapier, A. Garnier, and V. Veksler Energy metabolism in heart failure J. Physiol. 555 2004 1 13
29. C.F. Bentzinger, K. Romanino, D. Cloëtta, S. Lin, J.B. Mascarenhas, F. Oliveri, J. Xia, E. Casanova, C.F. Costa, M. Brink, F. Zorzato, M.N. Hall, and M.A. Rüegg Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy Cell Metab. 8 2008 411 424
30. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241
31. G. Kulik, and M.J. Weber Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I Mol. Cell. Biol. 18 1998 6711 6718